Clinical Trials Logo

Macrosomia, Fetal clinical trials

View clinical trials related to Macrosomia, Fetal.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06281301 Recruiting - Macrosomia, Fetal Clinical Trials

Improving Patient Understanding of Macrosomia

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a graphic based education tool on patient knowledge of macrosomia through the use of a survey and to evaluate knowledge at 1-2 weeks after initial review of the education tool.

NCT ID: NCT06048510 Recruiting - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

GLYCAGEST
Start date: December 18, 2023
Phase: N/A
Study type: Interventional

Gestational diabetes mellitus (GDM) increases the risk of macrosomia and other adverse pregnancy outcomes. Screening strategies are debated: universal vs. selective, and macrosomia may begin before the time of screening, suggesting that glycation markers may have an interest. The objective of this trail is to compare novel markers: skin autofluorescence and glycated albumin, to HbA1c (reference) as predictors of GDM, macrosomia and other adverse outcomes, in pregnant women.

NCT ID: NCT05410080 Recruiting - Clinical trials for Gestational Diabetes

the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome

Start date: June 15, 2022
Phase:
Study type: Observational

To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of adverse perinatal outcome among diabetic pregnant women.